Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Journal of Chemical Information and Modeling|December 9, 2014
Computer-aided structure-based design of multitarget leads for Alzheimer's diseaseJosé L Domínguez, Fernando Fernández-Nieto, Marian Castro, et al.
European Journal of Medicinal Chemistry|April 5, 2024
Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insultsFrancesco Samarelli, Rosa Purgatorio, Gianfranco Lopopolo, et al.
Chemmedchem|May 1, 2015
Multitarget-directed tricyclic pyridazinones as G protein-coupled receptor ligands and cholinesterase inhibitorsAmedeo Pau, Marco Catto, Giovanni Pinna, et al.
Antioxidants (Basel, Switzerland)|September 23, 2022
Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer's DiseaseAlessia Carocci, Alexia Barbarossa, Rosalba Leuci, et al.
Bioorganic Chemistry|October 25, 2024
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer's drug candidatesRosalba Leuci, Stefan Simic, Antonio Carrieri, et al.
Chemmedchem|July 28, 2020
Scouting around 1,2,3,4-Tetrahydrochromeno[3,2-c]pyridin-10-ones for Single- and Multitarget Ligands Directed towards Relevant Alzheimer's TargetsRosa Purgatorio, Larisa N Kulikova, Leonardo Pisani, et al.
ACS Chemical Neuroscience|January 4, 2021
Away from Flatness: Unprecedented Nitrogen-Bridged Cyclopenta[<i>a</i>]indene Derivatives as Novel Anti-Alzheimer Multitarget AgentsAlexander A Titov, Maxim S Kobzev, Marco Catto, et al.
International Journal of Molecular Sciences|May 13, 2023
Chemical and Biological Evaluation of Novel 1<i>H</i>-Chromeno[3,2-<i>c</i>]pyridine Derivatives as MAO Inhibitors Endowed with Potential Anticancer ActivityLarisa N Kulikova, Rosa Purgatorio, Andrey A Beloglazkin, et al.
European Journal of Medicinal Chemistry|April 24, 2022
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's diseaseLeonardo Brunetti, Rosalba Leuci, Antonio Carrieri, et al.
European Journal of Medicinal Chemistry|May 13, 2023
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitorsMariagrazia Rullo, Gabriella La Spada, Daniela Valeria Miniero, et al.
Pageof 12